Colorectal Cancer Disparity in African Americans: Risk Factors and Carcinogenic Mechanisms

American Journal of Pathology

Volumn 188, Issue 2, 2018, Pages 291-303

  Augustus, Gaius J ^a   Ellis, Nathan A ^b,c  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VITAMIN D;

AFRICAN AMERICAN; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; COLON CARCINOGENESIS; COLORECTAL CANCER; DIETARY INTAKE; DISEASE ASSOCIATION; EPIGENETICS; GASTROINTESTINAL ENDOSCOPY; GENE CONTROL; GENETIC RISK; HEALTH DISPARITY; HUMAN; INTESTINE FLORA; MICROSATELLITE INSTABILITY; POPULATION RISK; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SOMATIC MUTATION; TREND STUDY; VITAMIN BLOOD LEVEL; BLOOD; CELL TRANSFORMATION; COLORECTAL TUMOR; EPIDEMIOLOGY; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; INCIDENCE; MUTATION; STATISTICS AND NUMERICAL DATA; UNITED STATES;

AFRICAN AMERICANS; CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; GENETIC PREDISPOSITION TO DISEASE; HEALTH STATUS DISPARITIES; HUMANS; INCIDENCE; MUTATION; RISK FACTORS; UNITED STATES; VITAMIN D;

EID: 85044583162     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2017.07.023     Document Type: Review

References (116)

1. Siegel, R.L., Miller, K.D., Jemal, A., Cancer statistics, 2016. CA Cancer J Clin 66 (2016), 7–30.
2. Siegel, R., DeSantis, C., Jemal, A., Colorectal cancer statistics, 2014. CA Cancer J Clin 64 (2014), 104–117.
3. Dimou, A., Syrigos, K.N., Saif, M.W., Disparities in colorectal cancer in African-Americans vs whites: before and after diagnosis. World J Gastroenterol 15 (2009), 3734–3743.
4. Alexander, D.D., Waterbor, J., Hughes, T., Funkhouser, E., Grizzle, W., Manne, U., African-American and Caucasian disparities in colorectal cancer mortality and survival by data source: an epidemiologic review. Cancer Biomark 3 (2007), 301–313.
5. Agrawal, S., Bhupinderjit, A., Bhutani, M.S., Boardman, L., Nguyen, C., Romero, Y., Srinivasan, R., Figueroa-Moseley, C., Colorectal cancer in African Americans. Am J Gastroenterol 100 (2005), 515–523.
6. Rex, D.K., Johnson, D.A., Anderson, J.C., Schoenfeld, P.S., Burke, C.A., Inadomi, J.M., American College of Gastroenterology guidelines for colorectal cancer screening 2009. Am J Gastroenterol 104 (2009), 739–750.
7. Carethers, J.M., Screening for colorectal cancer in African Americans: determinants and rationale for an earlier age to commence screening. Dig Dis Sci 60 (2015), 711–721.
8. Powe, B.D., Faulkenberry, R., Harmond, L., A review of intervention studies that seek to increase colorectal cancer screening among African Americans. Am J Health Promot 25 (2010), 92–99.
9. Ashktorab, H., Vilmenay, K., Brim, H., Laiyemo, A.O., Kibreab, A., Nouraie, M., Colorectal cancer in young African Americans: is it time to revisit guidelines and prevention?. Dig Dis Sci 61 (2016), 3026–3030.
10. Lichtenstein, P., Holm, N., Verkasalo, P., Iliadou, A., Kaprio, J., Koskenvuo, M., Pukkala, E., Skytthe, A., Hemminki, K., Environmental and heritable factors in the causation of cancer analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343 (2000), 78–85.
11. Kupfer, S.S., Ellis, N.A., Hereditary colorectal cancer. Coleman, W.B., Tsongalis, G.J., (eds.) Molecular Basis of Human Cancer, 2017, Springer, New York, NY, 381–400.
12. Krausova, M., Korinek, V., Wnt signaling in adult intestinal stem cells and cancer. Cell Signal 26 (2014), 570–579.
13. Poulsen, M.L., Bisgaard, M.L., MUTYH associated polyposis (MAP). Curr Genomics 6 (2008), 420–435.
14. Jiao, S., Peters, U., Berndt, S., Brenner, H., Butterbach, K., Caan, B.J., Carlson, C.S., Chan, A.T., Chang-Claude, J., Chanock, S., Curtis, K.R., Duggan, D., Gong, J., Harrison, T.A., Hayes, R.B., Henderson, B.E., Hoffmeister, M., Kolonel, L.N., Le Marchand, L., Potter, J.D., Rudolph, A., Schoen, R.E., Seminara, D., Slattery, M.L., White, E., Hsu, L., Estimating the heritability of colorectal cancer. Hum Mol Genet 23 (2014), 3898–3905.
15. Weber, T.K., Chin, H.M., Rodriguez-Bigas, M., Keitz, B., Gilligan, R., O'Malley, L., Urf, E., Diba, N., Pazik, J., Petrelli, N.J., Novel hMLH1 and hMSH2 germline mutations in African Americans with colorectal cancer. JAMA 281 (1999), 2316–2320.
16. Inra, J.A., Steyerberg, E.W., Grover, S., McFarland, A., Syngal, S., Kastrinos, F., Racial variation in frequency and phenotypes of APC and MUTYH mutations in 6,169 individuals undergoing genetic testing. Genet Med 17 (2015), 1–7.
17. Guindalini, R.S.C., Win, A.K., Gulden, C., Lindor, N.M., Newcomb, P.A., Haile, R.W., Raymond, V., Stoffel, E., Hall, M., Llor, X., Ukaegbu, C.I., Solomon, I., Weitzel, J., Kalady, M., Blanco, A., Terdiman, J., Shuttlesworth, G.A., Lynch, P.M., Hampel, H., Lynch, H.T., Jenkins, M.A., Olopade, O.I., Kupfer, S.S., Mutation spectrum and risk of colorectal cancer in African American families with Lynch syndrome. Gastroenterology 149 (2015), 1446–1453.
18. Peters, U., Bien, S., Zubair, N., Genetic architecture of colorectal cancer. Gut 31 (2015), 1623–1636.
19. Wang, H., Haiman, C.A., Burnett, T., Fortini, B.K., Kolonel, L.N., Henderson, B.E., Signorello, L.B., Blot, W.J., Keku, T.O., Berndt, S.I., Newcomb, P.A., Pande, M., Amos, C.I., West, D.W., Casey, G., Sandler, R.S., Haile, R., Stram, D.O., Le Marchand, L., Fine-mapping of genome-wide association study-identified risk loci for colorectal cancer in African Americans. Hum Mol Genet 22 (2013), 5048–5055.
20. Kupfer, S.S., Anderson, J.R., Hooker, S., Skol, A., Kittles, R.A., Keku, T.O., Sandler, R.S., Ellis, N.A., Genetic heterogeneity in colorectal cancer associations between African and European Americans. Gastroenterology 139 (2010), 1677–1685.
21. Kupfer, S.S., Skol, A.D., Hong, E., Ludvik, A., Kittles, R.A., Keku, T.O., Sandler, R.S., Ellis, N.A., Shared and independent colorectal cancer risk alleles in TGFβ-related genes in African and European Americans. Carcinogenesis 35 (2014), 2025–2030.
22. Lemire, M., Qu, C., Loo, L.W.M., Zaidi, S.H.E., Wang, H., Berndt, S.I., et al. A genome-wide association study for colorectal cancer identifies a risk locus in 14q23.1. Hum Genet 134 (2015), 1249–1262.
23. Wang, H., Burnett, T., Kono, S., Haiman, C.A., Iwasaki, M., Wilkens, L.R., et al. Trans-ethnic genome-wide association study of colorectal cancer identifies a new susceptibility locus in VTI1A. Nat Commun, 5, 2014, 4613.
24. Wang, H., Schmit, S.L., Haiman, C.A., Keku, T.O., Kato, I., Palmer, J.R., van den Berg, D., Wilkens, L.R., Burnett, T., Conti, D.V., Schumacher, F.R., Signorello, L.B., Blot, W.J., Zanetti, K.A., Harris, C., Pande, M., Berndt, S.I., Newcomb, P.A., West, D.W., Haile, R., Stram, D.O., Figueiredo, J.C., Le Marchand, L., Le Marchand, L., Novel colon cancer susceptibility variants identified from a genome-wide association study in African Americans. Int J Cancer 140 (2017), 2728–2733.
25. Zeng, C., Matsuda, K., Jia, W.H., Chang, J., Kweon, S.S., Xiang, Y.B., et al. Identification of susceptibility loci and genes for colorectal cancer risk. Gastroenterology 150 (2016), 1633–1645.
26. Holick, M.F., Chen, T.C., Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 87 (2008), 1080S–1086S.
27. Giovannucci, E., Vitamin D and cancer incidence in the Harvard cohorts. Ann Epidemiol 19 (2009), 84–88.
28. Woolcott, C.G., Wilkens, L.R., Nomura, A.M., Horst, R.L., Goodman, M.T., Murphy, S.P., Henderson, B.E., Kolonel, L.N., Le Marchand, L., Plasma 25-hydroxyvitamin D levels and the risk of colorectal cancer: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 19 (2010), 130–134.
29. Fichera, A., Little, N., Dougherty, U., Mustafi, R., Cerda, S., Li, Y.C., Delgado, J., Arora, A., Campbell, L.K., Joseph, L., Hart, J., Noffsinger, A., Bissonnette, M., A vitamin D analogue inhibits colonic carcinogenesis in the AOM/DSS model. J Surg Res 142 (2007), 239–245.
30. Matsuoka, L.Y., Wortsman, J., Haddad, J.G., Kolm, P., Hollis, B.W., Racial pigmentation and the cutaneous synthesis of vitamin-D. Arch Dermatol 127 (1991), 536–538.
31. Grant, W.B., Peiris, A.N., Differences in vitamin D status may account for unexplained disparities in cancer survival rates between African and white Americans. Dermatoendocrinol 4 (2012), 85–94.
32. Fiscella, K., Winters, P., Tancredi, D., Hendren, S., Franks, P., Racial disparity in death from colorectal cancer: does vitamin D deficiency contribute?. Cancer 117 (2011), 1061–1069.
33. Zheng, X.E., Lipka, S., Li, T., Shahzad, G., Levine, E., Vlacancich, R., Takeshige, U., Mustacchia, P., The relationship of vitamin D status, smoking, and colorectal adenoma: a retrospective study in an ethnically diverse community. J Steroid Biochem Mol Biol 136 (2013), 280–283.
34. LePane, C.A., Singh, G., Spanier-Stiasny, J.A., Svinarich, D.M., Rasansky, R.J., Hoffman, S.M.J., Implications of serum 25-hydroxyvitamin D on the prevalence of neoplastic polyps: a cross-sectional study. Gastroenterol Res 4 (2011), 43–50.
35. Ashktorab, H., Nguza, B., Fatemi, M., Nouraie, M., Smoot, D.T., Schäffer, A.A., Kupfer, S.S., Camargo, C.A. Jr., Brim, H., Case-control study of vitamin D, dickkopf homolog 1 (DKK1) gene methylation, VDR gene polymorphism and the risk of colon adenoma in African Americans. PLoS One, 6, 2011, e25314.
36. Ahmad II, Trikudanathan, G., Feinn, R., Anderson, J.C., Nicholson, M., Lowe, S., Levine, J.B., Low serum vitamin D: a surrogate marker for advanced colon adenoma?. J Clin Gastroenterol 50 (2016), 644–648.
37. Baron, J.A., Barry, E.L., Mott, L.A., Rees, J.R., Sandler, R.S., Snover, D.C., Bostick, R.M., Ivanova, A., Cole, B.F., Ahnen, D.J., Beck, G.J., Bresalier, R.S., Burke, C.A., Church, T.R., Cruz-Correa, M., Figueiredo, J.C., Goodman, M., Kim, A.S., Robertson, D.J., Rothstein, R., Shaukat, A., Seabrook, M.E., Summers, R.W., A trial of calcium and vitamin D for the prevention of colorectal adenomas. N Engl J Med 373 (2015), 1519–1530.
38. Slattery, M.L., Herrick, J., Wolff, R.K., Caan, B.J., Potter, J.D., Sweeney, C., CDX2 VDR polymorphism and colorectal cancer. Cancer Epidemiol Biomarkers Prev 16 (2007), 2752–2755.
39. Kupfer, S.S., Anderson, J.R., Ludvik, A.E., Hooker, S., Skol, A., Kittles, R.A., Keku, T.O., Sandler, R.S., Ruiz-Ponte, C., Castellvi-Bel, S., Castells, A., Carracedo, A., Ellis, N.A., Genetic associations in the vitamin D receptor and colorectal cancer in African Americans and Caucasians. PLoS One, 6, 2011, e26123.
40. Pibiri, F., Kittles, R.A., Sandler, R.S., Keku, T.O., Kupfer, S.S., Xicola, R.M., Llor, X., Ellis, N.A., Genetic variation in vitamin D-related genes and risk of colorectal cancer in African Americans. Cancer Causes Control 25 (2014), 561–570.
41. Hiraki, L.T., Qu, C., Hutter, C.M., Baron, J.A., Berndt, S.I., Bézieau, S., et al. Genetic predictors of circulating 25-hydroxyvitamin D and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 22 (2013), 2037–2046.
42. 3 supplementation, and risk of colorectal adenomas. JAMA Oncol, 10, 2016, e0124339.
43. Alleyne, D., Witonsky, D.B., Mapes, B., Nakagome, S., Sommars, M., Hong, E., Muckala, K.A., Di Rienzo, A., Kupfer, S.S., Colonic transcriptional response to 1a,25(OH) 2 vitamin D 3 in African- and European-Americans. J Steroid Biochem Mol Biol 168 (2017), 49–59.
44. Hulur, I., Gamazon, E.R., Skol, A.D., Xicola, R.M., Llor, X., Onel, K., Ellis, N.A., Kupfer, S.S., Enrichment of inflammatory bowel disease and colorectal cancer risk variants in colon expression quantitative trait loci. BMC Genomics, 16, 2015, 138.
45. Moradi, T., Delfino, R.J., Bergström, S.R., Yu, E.S., Adami, H.O., Yuen, J., Cancer risk among Scandinavian immigrants in the US and Scandinavian residents compared with US whites, 1973-89. Eur J Cancer Prev 7 (1998), 117–125.
46. Flood, D.M., Weiss, N.S., Cook, L.S., Emerson, J.C., Schwartz, S.M., Potter, J.D., Colorectal cancer incidence in Asian migrants to the United States and their descendants. Cancer Causes Control 11 (2000), 403–411.
47. Willett, W.C., Stampfer, M.J., Current evidence on healthy eating. Annu Rev Public Health 34 (2013), 77–95.
48. Potter, J.D., Nutritional epidemiology: there's life in the old dog yet!. Cancer Epidemiol Biomarkers Prev 24 (2015), 323–330.
49. Ananthakrishnan, A.N., Du, M., Berndt, S.I., Brenner, H., Caan, B.J., Casey, G., Chang-Claude, J., Duggan, D., Fuchs, C.S., Gallinger, S., Giovannucci, E.L., Harrison, T.A., Hayes, R.B., Hoffmeister, M., Hopper, J.L., Hou, L., Hsu, L., Jenkins, M.A., Kraft, P., Ma, J., Nan, H., Newcomb, P.A., Ogino, S., Potter, J.D., Seminara, D., Slattery, M.L., Thornquist, M., White, E., Wu, K., Peters, U., Chan, A.T., Red meat intake, NAT2, and risk of colorectal cancer: a pooled analysis of 11 studies. Cancer Epidemiol Biomarkers Prev 24 (2015), 198–205.
50. Chan, D.S.M., Lau, R., Aune, D., Vieira, R., Greenwood, D.C., Kampman, E., Norat, T., Red and processed meat and colorectal cancer incidence: meta-analysis of prospective studies. PLoS One, 6, 2011, e20456.
51. Satia, J.A., Tseng, M., Galanko, J.A., Martin, C., Sandler, R.S., Dietary patterns and colon cancer risk in whites and African Americans in the North Carolina Colon Cancer Study. Nutr Cancer 61 (2009), 179–193.
52. Williams, C.D., Satia, J.A., Adair, L.S., Stevens, J., Galanko, J., Keku, T.O., Sandler, R.S., Dietary patterns, food groups, and rectal cancer risk in whites and African-Americans. Cancer Epidemiol Biomarkers Prev 18 (2009), 1552–1561.
53. Gill, S.R., Pop, M., Deboy, R.T., Eckburg, P.B., Turnbaugh, P.J., Samuel, B.S., Gordon, J.I., Relman, D.A., Fraser-Liggett, C.M., Nelson, K.E., Metagenomic analysis of the human distal gut microbiome. Science 312 (2006), 1355–1359.
54. Hooper, L.V., Gordon, J.I., Commensal host-bacterial relationships in the gut. Science 292 (2001), 1115–1118.
55. Drewes, J.L., Housseau, F., Sears, C.L., Sporadic colorectal cancer: microbial contributors to disease prevention, development and therapy. Br J Cancer 115 (2016), 273–280.
56. Sears, C.L., Garrett, W.S., Microbes, microbiota, and colon cancer. Cell Host Microbe 15 (2014), 317–328.
57. O'Keefe, S.J.D., Li, J.V., Lahti, L., Ou, J., Carbonero, F., Mohammed, K., Posma, J.M., Kinross, J., Wahl, E., Ruder, E., Vipperla, K., Naidoo, V., Mtshali, L., Tims, S., Puylaert, P.G.B., DeLany, J., Krasinskas, A., Benefiel, A.C., Kaseb, H.O., Newton, K., Nicholson, J.K., de Vos, W.M., Gaskins, H.R., Zoetendal, E.G., Fat, fibre and cancer risk in African Americans and rural Africans. Nat Commun, 6, 2015, 6342.
58. Ridlon, J.M., Harris, S.C., Bhowmik, S., Kang, D.J., Hylemon, P.B., Consequences of bile salt biotransformations by intestinal bacteria. Gut Microbes 7 (2016), 22–39.
59. Tsuei, J., Chau, T., Mills, D., Wan, Y.-J.Y., Bile acid dysregulation, gut dysbiosis, and gastrointestinal cancer. Exp Biol Med (Maywood) 239 (2014), 1489–1504.
60. Yazici, C., Wolf, P.G., Kim, H., Cross, T.-W.L., Vermillion, K., Carroll, T., Augustus, G.J., Mutlu, E., Tussing-Humphreys, L., Braunschweig, C., Xicola, R.M., Jung, B., Llor, X., Ellis, N.A., Gaskins, H.R., Race-dependent association of sulfidogenic bacteria with colorectal cancer. Gut 66 (2017), 1983–1994.
61. Goodwin, P.J., Stambolic, V., Impact of the obesity epidemic on cancer. Annu Rev Med 66 (2015), 281–296.
62. Iyengar, N.M., Hudis, C.A., Dannenberg, A.J., Obesity and cancer: local and systemic mechanisms. Annu Rev Med 66 (2015), 297–309.
63. Pereira, M.A., Kartashov, A.I., Ebbeling, C.B., Van Horn, L., Slattery, M.L., Jacobs, P.D.R., Ludwig, D.S., Fast-food habits, weight gain, and insulin resistance (the CARDIA study): 15-year prospective analysis. Lancet 365 (2005), 36–42.
64. Harris, M.I., Noninsulin-dependent diabetes mellitus in black and white Americans. Diabetes Metab Rev 6 (1990), 71–90.
65. Tsai, C.J., Giovannucci, E.L., Hyperinsulinemia, insulin resistance, vitamin D, and colorectal cancer among whites and African Americans. Dig Dis Sci 57 (2012), 2497–2503.
66. Gaillard, T., Schuster, D., Osei, K., Metabolic syndrome in black people of the African diaspora: the paradox of current classification, definition and criteria. Ethn Dis, 19, 2009 S2-1-7.
67. Desantis, C.E., Siegel, R.L., Sauer, A.G., Miller, K.D., Fedewa, S.A., Alcaraz, K.I., Jemal, A., Cancer statistics for African Americans, 2016: progress and opportunities in reducing racial disparities. CA Cancer J Clin 66 (2016), 290–308.
68. Vilar, E., Gruber, S.B., Microsatellite instability in colorectal cancer: the stable evidence. Nat Rev Clin Oncol 7 (2010), 153–162.
69. Le, D.T., Uram, J.N., Wang, H., Bartlett, B.R., Kemberling, H., Eyring, A.D., Skora, A.D., Luber, B.S., Azad, N.S., Laheru, D., Biedrzycki, B., Donehower, R.C., Zaheer, A., Fisher, G.A., Crocenzi, T.S., Lee, J.J., Duffy, S.M., Goldberg, R.M., de la Chapelle, A., Koshiji, M., Bhaijee, F., Huebner, T., Hruban, R.H., Wood, L.D., Cuka, N., Pardoll, D.M., Papadopoulos, N., Kinzler, K.W., Zhou, S., Cornish, T.C., Taube, J.M., Anders, R.A., Eshleman, J.R., Vogelstein, B., Diaz, L.A. Jr., PD-1 blockade in tumors with mismatch-repair deficiency. N Engl J Med 372 (2015), 2509–2520.
70. Ashktorab, H., Smoot, D.T., Carethers, J.M., Rahmanian, M., Kittles, R., Vosganian, G., Doura, M., Nidhiry, E., Naab, T., Momen, B., Shakhani, S., Giardiello, F.M., High incidence of microsatellite instability in colorectal cancer from African Americans. Clin Cancer Res 9 (2003), 1112–1117.
71. Ashktorab, H., Smoot, D.T., Farzanmehr, H., Fidelia-Lambert, M., Momen, B., Hylind, L., Iacosozio-Dononue, C., Carethers, J.M., Goel, A., Boland, C.R., Giardiello, F.M., Clinicopathological features and microsatellite instability (MSI) in colorectal cancers from African Americans. Int J Cancer 116 (2005), 914–919.
72. Brim, H., Mokarram, P., Naghibalhossaini, F., Saberi-Firoozi, M., Al-Mandhari, M., Al-Mawaly, K., Al-Mjeni, R., Al-Sayegh, A., Raeburn, S., Lee, E., Giardiello, F., Smoot, D.T., Vilkin, A., Boland, C.R., Goel, A., Hafezi, M., Nouraie, M., Ashktorab, H., Impact of BRAF, MLH1 on the incidence of microsatellite instability high colorectal cancer in populations based study. Mol Cancer, 7, 2008, 68.
73. Eaton, A.M., Sandler, R., Carethers, J.M., Millikan, R.C., Galanko, J., Keku, T.O., 5,10-Methylenetetrahydrofolate reductase 677 and 1298 polymorphisms, folate intake, and microsatellite instability in colon cancer. Cancer Epidemiol Biomarkers Prev 14 (2005), 2023–2029.
74. Sylvester, B.E., Huo, D., Khramtsov, A., Zhang, J., Smalling, R.V., Olugbile, S., Polite, B.N., Olopade, O.I., Molecular analysis of colorectal tumors within a diverse patient cohort at a single institution. Clin Cancer Res 18 (2012), 350–359.
75. Carethers, J.M., Murali, B., Yang, B., Doctolero, R.T., Tajima, A., Basa, R., Julieta Smith, E., Lee, M., Janke, R., Ngo, T., Tejada, R., Ji, M., Kinseth, M., Cabrera, B.L., Miyai, K., Keku, T.O., Martin, C.F., Galanko, J.A., Sandler, R.S., McGuire, K.L., Influence of race on microsatellite instability and CD8+ T cell infiltration in colon cancer. PLoS One, 9, 2014, e100461.
76. Xicola, R.M., Gagnon, M., Clark, J.R., Carroll, T., Gao, W., Fernandez, C., Mijic, D., Rawson, J.B., Janoski, A., Pusatcioglu, C.K., Rajaram, P., Gluskin, A.B., Regan, M., Chaudhry, V., Abcarian, H., Blumetti, J., Cintron, J., Melson, J., Xie, H., Guzman, G., Emmadi, R., Alagiozian-Angelova, V., Kupfer, S.S., Braunschweig, C., Ellis, N.A., Llor, X., Excess of proximal microsatellite-stable colorectal cancer in African Americans from a multiethnic study. Clin Cancer Res 20 (2014), 4962–4970.
77. Ashktorab, H., Ahuja, S., Kannan, L., Llor, X., Ellis, N.A., Xicola, R.M., Laiyemo, A.O., Carethers, J.M., Brim, H., Nouraie, M., A meta-analysis of MSI frequency and race in colorectal cancer. Oncotarget 7 (2016), 34546–34557.
78. Ashktorab, H., Schäffer, A.A., Daremipouran, M., Smoot, D.T., Lee, E., Brim, H., Distinct genetic alterations in colorectal cancer. PLoS One, 5, 2010, e8879.
79. Varadan, V., Singh, S., Nosrati, A., Ravi, L., Lutterbaugh, J., Barnholtz-Sloan, J.S., Markowitz, S.D., Willis, J.E., Guda, K., ENVE: a novel computational framework characterizes copy-number mutational landscapes in African American colon cancers. Genome Med, 7, 2015, 69.
80. Brim, H., Lee, E., Abu-Asab, M.S., Chaouchi, M., Razjouyan, H., Namin, H., Goel, A., Schäffer, A.A., Ashktorab, H., Genomic aberrations in an African American colorectal cancer cohort reveals a MSI-specific profile and chromosome X amplification in male patients. PLoS One, 7, 2012, e40392.
81. Brim, H., Abu-Asab, M.S., Nouraie, M., Salazar, J., DeLeo, J., Razjouyan, H., Mokarram, P., Schäffer, A.A., Naghibhossaini, F., Ashktorab, H., An integrative CGH, MSI and candidate genes methylation analysis of colorectal tumors. PLoS One, 9, 2014, e82185.
82. Haugen, A.C., Goel, A., Yamada, K., Marra, G., Nguyen, T.P., Nagasaka, T., Kanazawa, S., Koike, J., Kikuchi, Y., Zhong, X., Arita, M., Shibuya, K., Oshimura, M., Hemmi, H., Boland, C.R., Koi, M., Genetic instability caused by loss of MutS homologue 3 in human colorectal cancer. Cancer Res 68 (2008), 8465–8472.
83. Devaraj, B., Lee, A., Cabrera, B.L., Miyai, K., Luo, L., Ramamoorthy, S., Keku, T., Sandler, R.S., McGuire, K.L., Carethers, J.M., Relationship of EMAST and microsatellite instability among patients with rectal cancer. J Gastrointest Surg 14 (2010), 1521–1528.
84. Ashktorab, H., Daremipouran, M., Devaney, J., Varma, S., Rahi, H., Lee, E., Shokrani, B., Schwartz, R., Nickerson, M.L., Brim, H., Identification of novel mutations by exome sequencing in African American colorectal cancer patients. Cancer 121 (2015), 34–42.
85. Guda, K., Veigl, M.L., Varadan, V., Nosrati, A., Ravi, L., Lutterbaugh, J., Beard, L., Willson, J.K.V., Sedwick, W.D., Wang, Z.J., Molyneaux, N., Miron, A., Adams, M.D., Elston, R.C., Markowitz, S.D., Willis, J.E., Novel recurrently mutated genes in African American colon cancers. Proc Natl Acad Sci U S A 112 (2015), 1149–1154.
86. Katkoori, V.R., Jia, X., Shanmugam, C., Wan, W., Meleth, S., Bumpers, H., Grizzle, W.E., Manne, U., Prognostic significance of p53 codon 72 polymorphism differs with race in colorectal adenocarcinoma. Clin Cancer Res 15 (2009), 2406–2416.
87. Kang, M., Shen, X.J., Kim, S., Araujo-Perez, F., Galanko, J.A., Martin, C.F., Sandler, R.S., Keku, T.O., Somatic gene mutations in African Americans may predict worse outcomes in colorectal cancer. Cancer Biomark 13 (2013), 359–366.
88. Boyd, A.W., Bartlett, P.F., Lackmann, M., Therapeutic targeting of EPH receptors and their ligands. Nat Rev Drug Discov 13 (2014), 39–62.
89. Wang, Z., Li, L., Guda, K., Chen, Z., Barnholtz-Sloan, J., Park, Y.S., Markowitz, S.D., Willis, J., Adverse clinical outcome associated with mutations that typify African American colorectal cancers. J Natl Cancer Inst, 108, 2016 pii: djw164.
90. Mokarram, P., Kumar, K., Brim, H., Naghibalhossaini, F., Saberifiroozi, M., Nouraie, M., Green, R., Lee, E., Smoot, D.T., Ashktorab, H., Distinct high-profile methylated genes in colorectal cancer. PLoS One, 4, 2009, e7012.
91. Fatemi, M., Paul, T.A., Brodeur, G.M., Shokrani, B., Brim, H., Ashktorab, H., Epigenetic silencing of CHD5, a novel tumor-suppressor gene, occurs in early colorectal cancer stages. Cancer 120 (2014), 172–180.
92. Ashktorab, H., Rahi, H., Wansley, D., Varma, S., Shokrani, B., Lee, E., Daremipouran, M., Laiyemo, A., Goel, A., Carethers, J.M., Brim, H., Toward a comprehensive and systematic methylome signature in colorectal cancers. Epigenetics 8 (2013), 807–815.
93. Ashktorab, H., Daremipouran, M., Goel, A., Varma, S., Leavitt, R., Sun, X., Brim, H., DNA methylome profiling identifies novel methylated genes in African American patients with colorectal neoplasia. Epigenetics 9 (2014), 503–512.
94. Peeters, P.J.H.L., Bazelier, M.T., Leufkens, H.G.M., de Vries, F., De Bruin, M.L., The risk of colorectal cancer in patients with type 2 diabetes: associations with treatment stage and obesity. Diabetes Care 38 (2015), 495–502.
95. Ashktorab, H., Shakoori, A., Zarnogi, S., Sun, X., Varma, S., Lee, E., Shokrani, B., Laiyemo, A.O., Washington, K., Brim, H., Reduced representation bisulfite sequencing determination of distinctive DNA hypermethylated genes in the progression to colon cancer in African Americans. Gastroenterol Res Pract, 2016, 2016, 2102674.
96. Wang, X., Ji, P., Zhang, Y., LaComb, J.F., Tian, X., Li, E., Williams, J.L., Aberrant DNA methylation: implications in racial health disparity. PLoS One 11 (2016), 1–16.
97. Taniguchi, K., Sugito, N., Kumazaki, M., Shinohara, H., Yamada, N., Nakagawa, Y., Ito, Y., Otsuki, Y., Uno, B., Uchiyama, K., Akao, Y., MicroRNA-124 inhibits cancer cell growth through PTB1/PKM1/PKM2 feedback cascade in colorectal cancer. Cancer Lett 363 (2015), 17–27.
98. Oberg, A.L., French, A.J., Sarver, A.L., Subramanian, S., Morlan, B.W., Riska, S.M., Borralho, P.M., Cunningham, J.M., Boardman, L.A., Wang, L., Smyrk, T.C., Asmann, Y., Steer, C.J., Thibodeau, S.N., miRNA expression in colon polyps provides evidence for a multihit model of colon cancer. PLoS One, 6, 2011, e20465.
99. Cekaite, L., Rantala, J.K., Bruun, J., Guriby, M., Agesen, T.H., Danielsen, S.A., Lind, G.E., Nesbakken, A., Kallioniemi, O., Lothe, R.A., Skotheim, R.I., MiR-9, -31, and -182 deregulation promote proliferation and tumor cell survival in colon cancer. Neoplasia 14 (2012), 868–879.
100. Guinney, J., Dienstmann, R., Wang, X., de Reyniès, A., Schlicker, A., Soneson, C., et al. The consensus molecular subtypes of colorectal cancer. Nat Med 21 (2015), 1350–1356.
101. Jovov, B., Araujo-Perez, F., Sigel, C.S., Stratford, J.K., McCoy, A.N., Yeh, J.J., Keku, T., Differential gene expression between African American and European American colorectal cancer patients. PLoS One, 7, 2012, e30168.
102. Bovell, L.C., Shanmugam, C., Putcha, B.D.K., Katkoori, V.R., Zhang, B., Bae, S., Singh, K.P., Grizzle, W.E., Manne, U., The prognostic value of microRNAs varies with patient race/ethnicity and stage of colorectal cancer. Clin Cancer Res 19 (2013), 3955–3965.
103. Li, E., Ji, P., Ouyang, N., Zhang, Y., Wang, X.Y., Rubin, D.C., Davidson, N.O., Bergamaschi, R., Shroyer, K.R., Burke, S., Zhu, W., Williams, J.L., Differential expression of miRNAs in colon cancer between African and Caucasian Americans: implications for cancer racial health disparities. Int J Oncol 45 (2014), 587–594.
104. Ogino, S., Chan, A.T., Fuchs, C.S., Giovannucci, E., Molecular pathologic epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field. Gut 3 (2011), 397–411.
105. Rabeneck, L., El-Serag, H., Davila, J., Sandler, R., Outcomes of colorectal cancer in the United States: no change in survival (1986-1997). Am J Gastroenterol 98 (2003), 471–477.
106. James, A.S., Campbell, M.K., DeVellis, B., Reedy, J., Carr, C., Sandler, R.S., Health behavior correlates among colon cancer survivors: NC STRIDES baseline results. Am J Health Behav 30 (2006), 720–730.
107. Polite, B.N., Dignam, J.J., Olopade, O.I., Colorectal cancer model of health disparities: understanding mortality differences in minority populations. J Clin Oncol 24 (2006), 2179–2187.
108. Alexander, D., Chatla, C., Funkhouser, E., Meleth, S., Grizzle, W.E., Manne, U., Postsurgical disparity in survival between African Americans and Caucasians with colonic adenocarcinoma. Cancer 101 (2004), 66–76.
109. Alexander, D., Jhala, N., Chatla, C., Steinhauer, J., Funkhouser, E., Coffey, C.S., Grizzle, W.E., Manne, U., High-grade tumor differentiation is an indicator of poor prognosis in African Americans with colonic adenocarcinomas. Cancer 103 (2005), 2163–2170.
110. Hines, R.B., Shanmugam, C., Waterbor, J.W., McGwin, G., Funkhouser, E., Coffey, C.S., Posey, J., Manne, U., Effect of comorbidity and body mass index on the survival of African-American and Caucasian patients with colon cancer. Cancer 115 (2009), 5798–5806.
111. Manne, U., Weiss, H.L., Myers, R.B., Danner, O.K., Moron, C., Srivastava, S., Grizzle, W.E., Nuclear accumulation of p53 in colorectal adenocarcinoma prognostic importance differs with race and location of the tumor. Cancer 83 (1998), 2456–2467.
112. Grizzle, W.E., Manne, U., Weiss, H.L., Jhala, N., Talley, L., Molecular staging of colorectal cancer in African-American and Caucasian patients using phenotypic expression of p53, Bcl-2, MUC-1 and p27kip-1. Int J Cancer 97 (2002), 403–409.
113. Manne, U., Weiss, H.L., Grizzle, W.E., Racial differences in the prognostic usefulness of MUC1 and MUC2 in colorectal adenocarcinomas. Clin Cancer Res 6 (2000), 4017–4025.
114. Manne, U., Weiss, H.L., Grizzle, W.E., Bcl-2 expression is associated with improved prognosis in patients with distal colorectal adenocarcinomas. Int J Cancer 89 (2000), 423–430.
115. Manne, U., Jhala, N.C., Jones, J., Weiss, H.L., Chatla, C., Meleth, S., Suarez-Cuervo, C., Grizzle, W.E., Prognostic significance of p27(kip-1) expression in colorectal adenocarcinomas is associated with tumor stage. Clin Cancer Res 10 (2004), 1743–1752.
116. Jones, B.A., Christensen, A.R., Wise, J.P., Yu, H., Glutathione S-transferase polymorphisms and survival in African-American and white colorectal cancer patients. Cancer Epidemiol 33 (2009), 249–256.